Candida E. Morley
Vermögen: 128 355 $ am 31.08.2026
Vermögen: 128 355 $ am 31.08.2026
Candida Morley has a Law Degree from Oxford and a Masters Degree in Small Business, together with extensive experience in investment banking / M&A (with Barings), venture capital (at 3i) and corporate development within a large plc (Harrisons & Crosfield).
She joined LDC in 2000.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.05.2026 | 23’999 ( 0.01% ) | 128 355 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PANTHEON INTERNATIONAL PLC | Direktor/Vorstandsmitglied | 31.01.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
Lloyds Development Capital (Holdings) Ltd.
Lloyds Development Capital (Holdings) Ltd. Investment ManagersFinance LDC invests in mid-market companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides financing for MBOs, secondary buyout, buy & build and development capital requirements with a minimum investment size of GBP 100 million. It acquires minority and majority stakes and makes follow on investments. | Private Equity Investor | 01.01.2015 |
Penn Pharmaceutical Services Ltd.
Penn Pharmaceutical Services Ltd. Pharmaceuticals: MajorHealth Technology Provides drug development, clinical trial supply and manufacturing services | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Pantheon International Plc
Pantheon International Plc Investment ManagersFinance Acts as Private Equity Fund | Finance |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lloyds Development Capital (Holdings) Ltd.
Lloyds Development Capital (Holdings) Ltd. Investment ManagersFinance LDC invests in mid-market companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides financing for MBOs, secondary buyout, buy & build and development capital requirements with a minimum investment size of GBP 100 million. It acquires minority and majority stakes and makes follow on investments. | Finance |
Penn Pharmaceutical Services Ltd.
Penn Pharmaceutical Services Ltd. Pharmaceuticals: MajorHealth Technology Provides drug development, clinical trial supply and manufacturing services | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen